AIM
CHRS icon

Assured Investment Management’s Coherus Oncology CHRS Stock Holding History

Assured Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,219
Closed -$11K – 1152
2018
Q4 		$11K Sell
1,219
-31,038
-96% -$359K ﹤0.01% 1082
2018
Q3 		$532K Buy
32,257
+16,960
+111% +$301K 0.01% 745
2018
Q2 		$214K Buy
+15,297
New +$219K ﹤0.01% 986

Other funds holding CHRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Assured Investment Management's CHRS Position: Q1 2019 in Review

Assured Investment Management sold out of Coherus Oncology (CHRS) in Q1 2019, closing a stake of 1,219 shares — an estimated $11K sold.

Assured Investment Management first reported a position in CHRS in Q2 2018 and held it in 3 quarters. The position peaked at $532K in Q3 2018. 117 funds tracked by Wall St. Rank hold CHRS as of Q1 2019.

  • Assured Investment Management reported no remaining Coherus Oncology position as of Q1 2019 after selling out during the quarter.
  • Assured Investment Management sold 1,219 Coherus Oncology shares in Q1 2019, an estimated $11K.
  • Assured Investment Management first reported a position in Coherus Oncology in Q2 2018 and held it in 3 quarters.
  • Assured Investment Management's Coherus Oncology position peaked at $532K in Q3 2018.
  • 117 funds tracked by Wall St. Rank held Coherus Oncology as of Q1 2019.

Based on Assured Investment Management's 13F filing for Q1 2019, filed 16 May 2019.